Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125421932 | 12542193 | 2 | F | 20160811 | 20160708 | 20160818 | EXP | GB-ASTRAZENECA-2016SE71713 | ASTRAZENECA | 70.00 | YR | F | Y | 0.00000 | 20160818 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125421932 | 12542193 | 1 | PS | ANASTROZOLE. | ANASTROZOLE | 1 | Oral | U | 20541 | TABLET | |||||||||
| 125421932 | 12542193 | 2 | SS | TRASTUZUMAB | TRASTUZUMAB | 1 | Subcutaneous | U | U | 0 | 600 | MG | TIW |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125421932 | 12542193 | 1 | Product used for unknown indication |
| 125421932 | 12542193 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125421932 | 12542193 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125421932 | 12542193 | Arthralgia | |
| 125421932 | 12542193 | Asthenia | |
| 125421932 | 12542193 | Cough | |
| 125421932 | 12542193 | Fatigue | |
| 125421932 | 12542193 | Joint stiffness | |
| 125421932 | 12542193 | Nasopharyngitis | |
| 125421932 | 12542193 | Pain in extremity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |